Hemostasis factors may influence the pathophysi ology of stroke. The role of brain hemostasis in ischemic hy pertensive brain injury is not known. We studied ischemic in jury in spontaneously hypertensive rats in relation to cerebro vascular fibrin deposition and activity of different hemostasis factors in brain microcirculation. In spontaneously hyperten sive rats subjected to transient middle cerebral artery occlusion versus normotensive Wistar-Kyoto (W-K) rats, infarct and edema volumes were increased by 6.1-fold (P < 0.001) and 5.S-fold (P < 0.001), respectively. the cerebral blood flow (CBF) reduced during middle cerebral artery occlusion (MCAO) by 55% (P < 0.01), motor neurologic score increased by 6.9-fold (P < 0.0 I), and cerebrovascular fibrin deposition
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Hypertension is a major factor that increases the risk of cardiovascular disease and ischemic stroke (Bots et aI., 1992; Cortellaro et aI., 1991; Sobel et aI., 1989) . It has been suggested that immunohematologic abnormali ties in plasma, impaired systemic fibrinolysis, and pro coagulant blood profile may play a role in the develop ment of cerebrovascular ischemic disease and thrombo embolic occlusions in stroke patients (Catto and Grant, 1995; De Stefano et aI., 1998; Fisher, 1995; Folsom et aI., 1999; Grau et aI., 1998 ; Levine et aI., 1997; Zlokovic, 1997; Zlokovic et aI., 1995a) . Prolonged clot lysis time, increased platelet aggregation, elevated plasma fibrino-increased by 6.S-fold (P < 0.01). Under basal conditions, brain capillary protein C activation and tissue plasminogen activator activity were reduced in spontaneously hypertensive rats com pared with Wistar-Kyoto rats by I LS-fold (P < 0.001) and 5.I-fold (P < 0.001), respectively, and the plasminogen activa tor inhibitor-I antigen and tissue factor activity were increased by 154-fold (P < 0.00001) and 74% (P < 0.01), respectively.
We suggest that hypertension reduces antithrombotic mecha nisms in brain microcirculation, which may enhance cerebro vascular fibrin deposition and microvascular obstructions dur ing transient focal cerebral ischemia, which results in greater neuronal injury. Key Words: Hypertension-Focal isch emia-Fibrin deposition-Microcirculation-Hemostasis.
gen, alterations in circulating components of the fibrino lytic system, i.e., lower plasma tissue plasminogen acti vator (tPA) activity and increased plasma plasminogen activator inhibitor-l (PAl-I), and a link between cere brovascular disease and deficiency in anticoagulant pro tein C have been documented in patients with mild es sential hypertension and carotid artery occlusion (Anzola et aI., 1993; Landin et aI., 1990 ; Lebedev et aI., 1991; Macko et aI., 1999; Winther et aI., 1991) .
Recent studies on brain hemostasis indicated that ce rebrovascular pathways including clot preventing (i.e., anticoagulant), clot dissolving (i.e., fibrinolytic), and clot forming (i.e., procoagulant) might critically influence the neuropathologic outcome after focal ischemic stroke (Schreiber et aI., 1998 ; Thomas et aI., 1994; Tran et aI., 1996; Wang et aI., 1998; Zlokovic et aI., 1995a,b ). An imbalance in brain capillary hemostasis between antico agulant (i.e., protein C-thrombomodulin [protein C-TM]), fibrinolytic (i.e., tPA-PAI-I), and procoagulant (i.e., tissue factor [TF]) pathways may lead to a signifi cant loss of antithrombotic functions in brain microcir culation, which in rodent models for stroke risk factors, is associated with reduced ischemic and/or postischemic cerebral blood flow (CBF) and enhanced brain injury (Kittaka et aI., 1996; Wang et aI., 1997a) . Brain endo thelial anti thrombotic function is also reduced by cyto kines (e.g., interleukin-l(3 and tumor necrosis factor 0') that are pathogenic mediators of ischemic stroke (Hal lenbeck, 1997; Wang et aI., 1997b) . It has been shown that microvascular brain fibrin deposition correlates with microvascular obstructions, CBF reductions, and the ex tent of brain injury caused by a transient focal ischemia in nonhuman primates (Okada et aI., 1994) and in tPA deficient mice (Tabrizi et aI., 1999) .
Limited information is available on brain hemostasis and ischemic neuronal injury in hypertensive patients or in experimental hypertension models. It has been ob served that fibrin-rich emboli dissolve slowly in sponta neously hypertensive rats (SHR) (Kimata et aI., 1991) .
SHR may also develop brain microvascular thrombosis after a provocative dose of Escherichia coli lipopolysac charide (Hallenbeck et aI., 1988) . Whether ischemic brain damage in SHR (Brosnan et aI., 1999; Duverger and MacKenzie, 1988; Prado et aI., 1996; Tagami et aI., 1999) is related to enhanced cerebrovascular thrombosis and alterations in brain hemostasis is not known. We hypothesized that specific vascular alterations in hemo stasis factors are responsible for changes in intravascular coagulation during an ischemic stress in SHR versus ge netically matched normotensive Wistar-Kyoto (W-K) rats, and this, in turn, could be related to accelerated fibrin formation, ischemic microvascular obstructions, and larger brain injuries in SHR. In this study, a transient middle cerebral artery occlusion (MCAO) (Lavine et aI., 1998) was used in SHR and W -K rats to determine isch emic hypertensive brain injury, cerebrovascular fibrin deposition, and microvascular obstructions in relation to the activity profile of brain anticoagulant, fibrinolytic, and procoagulant pathways.
MATERIALS AND METHODS
The studies were performed using male SHR and control 
Focal ischemia studies
Rats were deprived of food 12 hours before surgery. Revers ible MCAO was performed by using an intraluminal thread technique (Zea Longa et aI., 1989) as modified in our labora tory (Kittaka et aI., 1996; Lavine et aI., 1998) in SHR (n = 6), and control W-K (n = 5) rats. The procedure involved initial anesthesia with metofane and maintenance with 50 mg/kg pen tobarbital intraperitoneally. Atropine methyl nitrate (0.18 mg/ kg) was given intraperitoneally as premedication to prevent airway obstruction by mucus formation. 
Motor neurologic behavioral score
Neurologic examination was performed after 23 hours of reperfusion, just before the rats were killed. Neurologic out come was scored on the following 6-point scale as previously reported (Lavine et ai., 1998) : a score of 0 indicated no neu rologic deficit (normal); a score of I (failure to extend left forepaw fully), a mild focal neurologic deficit; a score of 2 (circling to the left), a moderate focal neurologic deficit; a score of 3 (falling to the left), a severe focal deficit; rats with a score of 4 did not walk spontaneously and had a depressed level of consciousness; and a score of 5 was stroke-related death.
Measurement of volume of injury
The area of injury was delineated by incubation of unfixed 2-mm coronal brain slices in 2% triphenyltetrazolium chloride lesioned hemispheres were calculated, and the amount of injury was expressed as a percentage of lesioned hemisphere and in absolute terms (expressed as cubic millimeters). The edema volume was calculated by subtracting the volume of the normal gray matter in the control hemisphere from the volume of gray matter in the lesioned hemisphere (Swanson et aI., 1990) . The total injury volume of gray matter corrected for edema was calculated by subtracting the edema volume from the volume of injury in the lesioned hemisphere (Swanson et aI., 1990) . Mea surements of the volume of injury were performed separately for the pallium and striatum. A coronal section from each brain was obtained at the level of the optic chiasm.
Histopathology
Detection of fibrin by immunostammg was performed on brain tissue sections previously treated with TTC as described (Tabrizi et aI., 1999) . Tissue fixed in 10% buffer formalin was processed and 4-fLm-thick paraffin coronal sections from each block cut and stained. Fibrin was localized by using the fol lowing grading scale (Tabrizi et aI., 1999 
Isolation of brain capillaries
Brain capillaries were isolated from SHR (n = 6) and con trol W-K rats (n = 6) rats by a modified mechanical homog enization technique (Zlokovic et aI., 1993) . In brief, brains were immediately removed from the skull and immersed in ice-cold buffer B (103 mmollL NaC!, 4.7 mmollL KCI, 2.5 mmollL CaCI2, 1.2 mmollL KHzP04, 1.2 mmollL MgS04, 15 mmollL HEPES, pH 7.4). The cerebral cortical mantles were rapidly freed of meninges (i.e., pial vessels), the arteries of the circle of Willis, veins and choroid plexi were discarded, and cerebral cortices used to isolate the capillaries. Brain homog enization in buffer A (buffer B + 25 mmollL HC03, 10 mmollL glucose, 1 mmollL sodium pyruvate, and 1 g/100 mL dextran, Mr = 64,000) with a handheld Teflon homogenizer was fol lowed by dextran-density centrifugation at 5,800 x g at 4°C.
The pellet was resuspended in buffer A and passed over an 85-mm nylon mesh. Arterioles and venules remained on top of the mesh, and the capillaries, red cells, nuclei, and other debris were collected in the filtrate passing through the mesh. This filtrate was then passed over a 3 x 4-cm glass bead column (0.45-mm glass beads), with 44-mm nylon mesh at the bottom, and the column washed with buffer B. The brain capillaries adhere to the glass beads while the other contaminants pass unimpeded. Capillaries were recovered by repeated gentle agi tation of the glass beads in buffer A, the supernatant with capillaries was decanted and spun at 500 x g for 5 minutes to obtain the final pellet. The purity of the cerebral capillary preparation was checked by light and phase microscopy. The cerebral capillaries were free of adjoining brain tissue, and preparations consisted primarily of capillaries but also con tained minor amounts (5% to 10%) of small arterioles, as de scribed (Zlokovic et aI., 1993 (Zlokovic et aI., , 1995b . Capillary-depleted brain homogenates were centrifuged again at 5,800 x g at 4°C (sec ond centrifugation) to obtain a final capillary-free brain super natant. The presence of no more than minimal detectable ac tivity of a specific cerebrovascular marker, ,),-glutamyl trans peptidase, was used to confirm the absence of contamination of capillary-depleted brains with microvessels but not to demon strate that the microvascular preparations are capillaries only.
Protein C activation
Capillaries were washed with phosphate-buffered saline three times (centrifugation at 10,000 rpm for 5 minutes), the microvascular pellet sonicated, resuspended in phosphate buffered saline and spun at 10,000 g for 5 minutes three times. In brief, the antigen in the sample was bound quantitatively to specific antibodies coated on the walls of the microtest strips.
A second horseradish peroxidase-coated antibody against the same antigen was then added to the antigen-antibody complex followed by an horseradish peroxidase substrate (OPD/H202).
The breakdown of the substrate yields a yellow product whose absorbance was measured at 492 nm on a microtest plate reader and calibrated against known antigen concentrations. The tPA fibrinolytic enzyme activity was determined by a chromogenic assay, using Chromolize tPA assay kit from Biopool, as de scribed (Yu et aI., 1999) . were analyzed by the use of electrophoresis on a 1% agarose gel.
TF activity assay
The rat TM primers (National Biosciences Inc.) were de signed from conserved cystine residue sites from the rat TM brain capillary sequence as reported (Wang et aI, 1998) . TM Preocclusion data were 10 minutes before MCA occlusion. For MCA occlusion, data at 10, 30. and 60 minutes (except for T) were pooled since there was no signifidant difference at different time points. For reperfusion. data at 10 and 60 minutes (except for T) were pooled since there was no significant difference. Data for T were 10 minutes before. and 60 minutes after MCA occlusion. and 60 minutes after reperfusion. Values are mean ± SO; n = 6 for SHR, and n = 5 for W-K rats. MABP. mean arterial blood pressure; T, temporalis muscle temperature; MCA, middle cerebral artery; W-K, Wi star-Kyoto; SHR, spontaneously hy pertensive rats. 
Statistical Analysis
Physiological variables, infarction and edema volumes, the amount of deposited fibrin, protein C activation, and tPA and TF activities were compared between groups by using a Stu dent's t-test and analysis of variance. Nonparametric data (neu rologic outcome scores) was subjected to the Kruskal-Wallis test. P < 0.05 was considered statistically significant.
RESULTS

Physiologic variables
There were no significant statistical differences in Values are mean ± SD. The number of CBF measurements during each studied period of time was 6 to 18 for the mean values listed in the table. Values are expressed as a percentage of baseline preocclusion CBF values determined within the 30 minute period before MCA occlusion in either group. CBF measurements were obtained on S animals in control W-K and SHR group. Student's I-test was used for comparisons between the two groups. MCA. middle cerebral artery; SHR, spontaneously hypertensive rats; W -K. Wi star-Kyoto; CBF. cerebral blood flow. Values are mean ± SD, n = 5 for control W-K group, and n = 6 for SHR group. P values were calculated by Student's t-test. W-K, Wistar Kyoto; SHR, spontaneously hypertensive rats.
Motor neurologic score
After 23 hours of reperfusion, the control W-K group had a mean neurologic score of 0.42 ± 0.18, and the SHR group had a score of 2.92 ± 0.52, an increase by 6.9-fold (P < 0.01, by Kruskal-Wallis test).
Neuropathology
The volume of injury corrected for edema volume, i.e., total infarct volume, was significantly increased in the SHR group by 6.1-fold relative to control W-K rats (Table 3) . Total edema volume was increased by 5.8-fold in the SHR. These increases were caused primarily by significant increase in injury volume in the pallium by 28.3-fold, and by a more modest 1.8-fold increase in injury volume in the striatum (Table 3) . Total area of brain injury determined at the level of optic chiasm and expressed as a percentage of the coronal sectional area was increased by 3.3-fold in SHR versus W-K rats. ( Fig. 3) . The relative increase in amount of fibrin in brain section IV (the level of optic chiasm) was about 6. I-fold based on Western blot analysis, whereas more moderate increases, between S2% and 98%, were found in sections II, III, and V. In the absence of ischemic challenge, there were no fibrin deposits in the brain under basal condi tions in either the SHR or W-K groups. Figure 4A illus trates that about 24% of microvessels in the ischemic hemisphere in SHR contained fibrin deposits, whereas only S% of vessels in the ischemic hemisphere in W-K rats were positive for fibrin. The amount of fibrin depos its determined by either Western blots or by counting positive vessels correlated well with the edema forma tion and brain injury in the two strains. No differences in endothelial lining, such as denudation that could precipi tate fibrin deposition, were observed in SHR group (Fig.   4B ), and fibrin deposition in control nonischemic hemi sphere was undetectable in either group.
Fibrin deposition
Brain capillary activity of hemostasis factors
As illustrated in Fig. SA , protein C activation in the brain capillaries in the SHR group was low, and there was 11.8-fold decrease in comparison with the W-K group. In contrast, TF activity was increased by 74% ( Fig. SB) . The tPA antigen levels in the brain capillaries of the SHR were 1.S times higher than those in W -K rats (Fig. SC) ; however, the tPA activity was reduced by S.l-fold ( Fig. SD) . Correspondingly, the PAI-l antigen levels in SHR were extremely high (i.e., 2.09 ± 0.40 ng/mg of protein); there was a IS4-fold increase in the PAI-l antigen in the SHR, compared with the levels in W-K rats, which were barely detectable (Fig. SE) .
Brain capillary mRNAs for hemostasis factors
RT-PCR analysis followed by scanning densitometry of bands revealed that brain capillary TM mRNA relative to l3-actin mRNA was decreased by 31 % in SHR versus W-K rats (Fig. 6A) . In contrast, tPA mRNA was in creased 4.6 times in the SHR versus the W-K rats (Fig.   6B ), whereas the PAI-l mRNA was almost undetectable in the SHR (Fig. 6C) . The TF mRNA, relative to l3-actin mRNA, was decreased 7.4-fold in the SHR versus the W-K rats (Fig. 6D ). After RT-PCR, the l3-actin mRNA band density was similar in capillary samples from SHR and W-K rats. Sequences of the mRNA in the bands obtained corresponded to published sequences of the re spective mRNAs. brin levels in 2-mm-thick brain sections from ischemic ipsilateral hemisphere in WoK rats and SHR determined by scanning densitometry (mean ± SO, n = 5 for WoK, and n = 6 for SHR). I-V, 2-mm-thick sections that were 0, 2, 4, 6, and 8 mm from 
DISCUSSION
The present study has demonstrated that anti throm botic mechanisms in brain microcirculation, including protein C activation and tPA activity, are significantly reduced in the SHR. In contrast, there was a pronounced increase in P AI-l antigen in brain capillaries in the SHR and a moderate increase in the activity of the procoagu lant TF pathway. An imbalance between local cerebro vascular anticoagulant, fibrinolytic, and procoagulant pathways may exacerbate cerebrovascular fibrin deposi tion and microvascular obstructions during focal isch emic insult in the SHR, which predisposes to greater brain injury compared with genetically matched normo tensive rats.
Previous studies indicated significant differences in the extent of ischemic brain injury, neuronal damage, and neurological deficit between the SHR and the ge netically matched W-K normotensive rats (Brosnan et aI., 1999; Carswell et aI., 1999; Duverger and MacKen zie, 1988; Grabowski et aI., 1988; Olsson et aI., 1989; Prado et aI., 1996; Tagami et aI., 1999; Yao et aI., 1997) .
Present findings suggest that fibrin formation may con tribute to the extent of ischemic brain injury in the SHR, may be unusual in the W-K rats, and, therefore, may represent a strain difference. Previous studies in nonhu man primates indicated that fibrin formation and depo sition relate to the extent of microvascular obstructions and ischemic parenchymal injury (Okada et aI., 1994) .
Cerebrovascular fibrin deposition also correlated with ischemic brain injury in tPA-deficient mice (Tabrizi et aI., 1999) . In the SHR, fibrin deposits were found in brain capillaries, venules and arterioles, as well as in brain parenchyma around some vessels in ischemic le sioned hemisphere. Fibrin immunostaining in SHR brains was restricted to the areas of parenchymal brain injury. In contrast, fibrin was barely detectable in nor motensive W-K rats that developed much smaller infarc tions with the present occlusion technique. Enhanced for mation of endogenous fibrin during cerebral ischemia in SHR fits well with previous observations that showed that spontaneous dissolution of fibrin clots injected into cerebral microcirculation was reduced in the SHR com pared with the W -K rats (Kimata et aI., 1991) .
A leakage of fibrinogen into brain parenchyma around some microvessels suggests a breakdown of the blood brain barrier during reperfusion (Okada et aI., 1994; Tabrizi et aI., 1999) . Faulty induction of blood-brain barrier functions by astrocytes in the SHR may favor disruption of the blood-brain barrier and widespread ce rebral lesions in the SHR, because the formation of brain endothelial tight junctions in the SHR is not as good as in normotensive rats (Yamagata et aI., 1997) . In addition, genetically altered astrocytes in the SHR may produce enormous quantities of lactic acid when cerebral isch emia develops (Yamagata et aI., 1997) . This, in turn, may exacerbate brain edema and hypoperfusion during MCAO in the SHR. Our results indicate that CBF de creases during MCAO by 55% in the SHR in comparison with normotensive rats. This important reduction in CBF could exacerbate massive intravascular coagulation (Hossmann and Hossmann, 1977; Kilic et aI., 1999) as a consequence of complement activation (Bottiger et aI., 1995) and the absence of significant brain antithrombotic mechanisms and enhanced procoagulation pathway in cerebral microvessels (Zlokovic et aI., 1995a) as well.
The formation of platelet plug or leukocyte-endothelial interactions (Palabrica et aI., 1992) Values are mean ± SD, n = 6. * P < 0.01. position in ischemic brain and impair significantly mi crocirculatory perfusion in acute stroke in the SHR even during early phases of MCAO (Dawson et al., 1996) . In fact, a significant contribution of leukocyte activation and platelet activation to microvascular occlusion forma tion could not take place without coincident fibrin depo sition (del Zoppo et al., 1991) . However, it is also true that fibrin deposition may occur independent of the other two cellular activations (Okada et al., 1994) .
During blood recirculation, CBF values in the SHR and normotensive rats were comparable except at the onset of reperfusion when CBF was elevated above con trol values in the SHR. These relatively higher CBF reperfusion values in the SHR could be related to higher cerebral perfusion pressure in the SHR caused by hyper tension. It has been reported that a transient elevation of blood pressure in acute stroke is not associated with an increase in morbidity or mortality (Rordorf et al., 1997) . (Tran et al., 1996; Wang et al., 1997b Wang et al., , 1998 , TM bound thrombin converts zymogen protein C to activated protein C, a serine protease that, with its nonenzymatic cofactor, protein S, inactivates coagulation factors V, Va, and VIlla by highly specific proteolysis, which yields inactive (i) factors Vi and VIlli (Griffin, 1995) , Low levels of activated protein C in brain microcirculation may fail to inactivate factors V, Va, and VIlla during an ischemic event in the SHR, thereby predisposing to mas sive intravascular coagulation. Plasma protein C is re garded as an inverse factor for ischemic stroke (Folsom et al., 1999) , and low plasma protein C levels and/or lower brain-specific protein C activation were related to poor neurologic outcome after stroke and/or during ca rotid occlusion in humans (Macko et al., 1996 (Macko et al., , 1999 Martinez et aI., 1993) .
Suppressed fibrinolytic tP A activity in the SHR and other rodent models for stroke, including diabetes, smok ing, and tPA deficiency, correlate with reduced CBF, larger brain infarcts (Kittaka et aI., 1996; Wang et al., 1997a) , and significant microvascular deposition of fi brin-rich thrombi (Tabrizi et aI., 1999) . In contrast to other stroke models in which the brain capillary pool of free tPA antigen is absent (Kittaka et al., 1996; Tabrizi et al., 1999; Wang et al., 1997a) , although the PAI-l anti gen remains unchanged (Wang et aI., 1997 a), in the SHR, a remarkable increase in the PAI-l antigen in brain capillaries seems to outweigh a modest increase in the 
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FIG. 6. Comparison of hemostasis factor mRNA between SHR and WoK rats. Whole RNA was extracted from freshly isolated cortical brain capillaries of SHR and WoK rats, and RT-PCR was performed using the respective primers. [3-actin primers were amplified as internal controls for nonchanging gene expression. (A, B , C, and 0) 1 % agarose gel stained with ethidium bromide showing RT-PCR products obtained with TM-specific, tPA-specific, PAI-1-specific, or TF-specific primers, respectively. Abundance of TM, tPA, PAI-1, TF mRNA was compared relative to [3-actin mRNA by scanning densitometry (right panels). Values in WoK rats were arbitrarily set as 1.
Error bars show SD, n = 6 rats. * P < 0.01.
tPA antigen and is, therefore, primarily responsible for significant reduction in tP A activity. The present study also demonstrated a moderate increase in procoagulant TF microvascular activity in the SHR. TF is normally associated with the abluminal side of brain micro vessels (del Zoppo et a!., 1992) and is a key factor for initiation of the coagulation cascade in brain (Zlokovic, 1997) . The experiments with anti-TF antibodies suggest that TF was responsible for intravascular fibrin formation, which was, in turn, partially responsible for occlusion (Okada et a!., 1994; Thomas et a\., 1994) . Blockade of TF, how ever, did not eliminate extravascular fibrin formation (Okada et a!., 1994) . It is conceivable that enhanced TF microvascular activity may contribute to fibrin formation after an ischemic insult in SHR.
Little is known about cellular events that regulate ce 
